West Pharmaceutical Services Q2 2026 Earnings
As seen on the 24/7 Wall St. homepage on July 23, 2026.
Q2 2026
EPS
$2.37
est $2.08
+13.9%
Revenue
$872M
est $840M
+3.8%
West Pharmaceutical's GLP-1 elastomers now represent 10% of total company revenue as the obesity drug boom accelerates, and the company is raising full-year EPS guidance to $8.85 to $9.05 on surging demand for high-value injectable drug delivery components.
Mentioned: WST